Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10328291rdf:typepubmed:Citationlld:pubmed
pubmed-article:10328291lifeskim:mentionsumls-concept:C0248868lld:lifeskim
pubmed-article:10328291lifeskim:mentionsumls-concept:C0024337lld:lifeskim
pubmed-article:10328291lifeskim:mentionsumls-concept:C0030956lld:lifeskim
pubmed-article:10328291lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:10328291lifeskim:mentionsumls-concept:C0205369lld:lifeskim
pubmed-article:10328291lifeskim:mentionsumls-concept:C1999216lld:lifeskim
pubmed-article:10328291lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:10328291lifeskim:mentionsumls-concept:C0185125lld:lifeskim
pubmed-article:10328291lifeskim:mentionsumls-concept:C0205250lld:lifeskim
pubmed-article:10328291lifeskim:mentionsumls-concept:C0770018lld:lifeskim
pubmed-article:10328291pubmed:issue8lld:pubmed
pubmed-article:10328291pubmed:dateCreated1999-8-3lld:pubmed
pubmed-article:10328291pubmed:abstractTextN(alpha)-Fmoc-N(epsilon)-(2-nitrobenzyloxycarbonyl)-lysine has been prepared and used in the solid-phase synthesis of caged peptides. The synthesized caged AIP (cagedKcagedKALRRQEAVDAL) showed characteristics required for caged peptides including a significantly reduced inhibitory activity to calmodulin-dependent protein kinase II and instantaneous recovery of the activity with photo-irradiation.lld:pubmed
pubmed-article:10328291pubmed:languageenglld:pubmed
pubmed-article:10328291pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10328291pubmed:citationSubsetIMlld:pubmed
pubmed-article:10328291pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10328291pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10328291pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10328291pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10328291pubmed:statusMEDLINElld:pubmed
pubmed-article:10328291pubmed:monthAprlld:pubmed
pubmed-article:10328291pubmed:issn0960-894Xlld:pubmed
pubmed-article:10328291pubmed:authorpubmed-author:FujisawaHHlld:pubmed
pubmed-article:10328291pubmed:authorpubmed-author:KameshitaIIlld:pubmed
pubmed-article:10328291pubmed:authorpubmed-author:IshidaAAlld:pubmed
pubmed-article:10328291pubmed:authorpubmed-author:TatsuYYlld:pubmed
pubmed-article:10328291pubmed:authorpubmed-author:ShigeriYYlld:pubmed
pubmed-article:10328291pubmed:authorpubmed-author:YumotoNNlld:pubmed
pubmed-article:10328291pubmed:issnTypePrintlld:pubmed
pubmed-article:10328291pubmed:day19lld:pubmed
pubmed-article:10328291pubmed:volume9lld:pubmed
pubmed-article:10328291pubmed:ownerNLMlld:pubmed
pubmed-article:10328291pubmed:authorsCompleteYlld:pubmed
pubmed-article:10328291pubmed:pagination1093-6lld:pubmed
pubmed-article:10328291pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:10328291pubmed:meshHeadingpubmed-meshheading:10328291...lld:pubmed
pubmed-article:10328291pubmed:meshHeadingpubmed-meshheading:10328291...lld:pubmed
pubmed-article:10328291pubmed:meshHeadingpubmed-meshheading:10328291...lld:pubmed
pubmed-article:10328291pubmed:meshHeadingpubmed-meshheading:10328291...lld:pubmed
pubmed-article:10328291pubmed:meshHeadingpubmed-meshheading:10328291...lld:pubmed
pubmed-article:10328291pubmed:year1999lld:pubmed
pubmed-article:10328291pubmed:articleTitleSynthesis of caged peptides using caged lysine: application to the synthesis of caged AIP, a highly specific inhibitor of calmodulin-dependent protein kinase II.lld:pubmed
pubmed-article:10328291pubmed:affiliationOsaka National Research Institute, AIST, Ikeda, Japan.lld:pubmed
pubmed-article:10328291pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:10328291lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10328291lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10328291lld:pubmed